NPI Details
DR. Muhammad Muzammil, MD is an internal medicine in Itasca, IL with 30 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Muhammad Muzammil, MD NPI is 1558320879. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1300 N ARLINGTON HEIGHTS RD STE 130
ITASCA, IL
ZIP 60143-128
Phone: (847) 871-4540
The NPI 1558320879 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
- Hemoglobin a1c level (HCPCS:83036)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
- Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Urine microalbumin (protein) level (HCPCS:82043)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
- Hospital discharge day management, 30 minutes or less (HCPCS:99238)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Vitamin d-3 level (HCPCS:82306)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Magnesium level (HCPCS:83735)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Iron level (HCPCS:83540)
- Blood test, clotting time (HCPCS:85610)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Ferritin (blood protein) level (HCPCS:82728)
- Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
- Initial hospital observation care per day, typically 70 minutes (HCPCS:99220)
The enumeration date for this NPI number is 3/23/2006 and was last updated on 8/16/2023.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 036112204 | ILLINOIS | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 036112204 | MEDICAID | ILLINOIS | |
